. . . . . . . . . . . . . . "p(EGID:24179) -> path(MESHD:Hypertrophy)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Similar effects were observed when NRVMs were treated with angiotensin II instead of PE (SI Appendix, Fig. S20)." . . "Selventa" . . . . "2014-07-03T14:33:39.963+02:00"^^ . . .